A Peek at Big Pharmaās Playbook That Leaves Many Americans Unable to Afford Their Drugs
Brand-name drug prices in the U.S. ā more than three times the price in other developed countries ā are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?